Takeda

ELAPRASE

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ELAPRASE – J1743

Manufacturer:

Takeda

Name:

ELAPRASE

HCPCS Code Descriptor:

Injection, idursulfase, 1 mg

Category:

J Code

HCPCS:

J1743

NDC(s):

54092-0700-01

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

ELAPRASE is an Enzyme Replacement Therapy drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J1743 is aligned to the drug ELAPRASE.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/08

HCPCS Effective Date:

1/1/08

HCPCS Short Description:

Idursulfase injection

Billing and Coding Guide:

https://www.elaprase.com/Content/pdf/resource-pdf/hcp/ELAPRASE%20Reimbursement%20Guide%20PDF.pdf

Patient Assistance:

https://www.elaprase.com/getting-started-support/onepath/

ELAPRASE - J1743